KMB vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

KMB

27.6
AI Score
VS
EMR Wins

EMR

49.9
AI Score

Investment Advisor Scores

KMB

28score
Recommendation
AVOID NEW MONEY

EMR

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric KMB EMR Winner
Forward P/E 13.1406 21.4592 KMB
PEG Ratio 2.0208 1.7818 EMR
Revenue Growth 0.6% 7.0% EMR
Earnings Growth -32.3% 23.0% EMR
Tradestie Score 27.6/100 49.9/100 EMR
Profit Margin 11.8% 13.8% EMR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD EMR

Relative Price Performance (Last 90 Days)

KMB 1M: +15.0% · 3M: +2.4% EMR 1M: +3.7% · 3M: +8.3%

Current Technical Phase

KMB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 74

RSI (14): 74.0 · Price: $112.32

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 53

RSI (14): 53.5 · Price: $160.29

Fundamentals Snapshot

Metric KMB EMR
Market Cap — —
Forward P/E 15.2 22.0
Trailing P/E 21.4 35.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.2% 0.3%
EPS 4.99 4.57
Dividend Yield 0.05% 0.01%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.